Sittner & Nelson, LLC Gsk PLC Transaction History

Sittner & Nelson, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $31,537 - $35,827	-750 Reduced 8.46%	8,117 $353,000
Q1 2022 May 10, 2022	BUY	$40.23 - $47.74 $1,931 - $2,291	48 Added 0.54%	8,867 $386,000
Q4 2021 Feb 09, 2022	SELL	$38.88 - $45.31 $1,516 - $1,767	-39 Reduced 0.44%	8,819 $389,000
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $58,185 - $64,739	1,500 Added 20.39%	8,858 $338,000
Q1 2021 May 06, 2021	BUY	$34.27 - $40.01 $4,283 - $5,001	125 Added 1.73%	7,358 $263,000
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $246,428 - $288,886	7,233 New	7,233 $266,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

Stay updated on Sittner & Nelson, LLC with notifications on news.